Small molecule discovery offers hope for treatment of Angelman syndrome

The Eu­ro­pean Med­i­cines Agency is con­cerned there could be a po­ten­tial link be­tween thy­roid can­cer and the use of glucagon-like pep­tide-1 (GLP-1) re­cep­tor ag­o­nists, which

Hicks is an associate professor of surgery and a director of clinical outcomes research. The recent New York Times article highlighting inappropriate treatment patterns among